Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$1.42M Sell
19,765
-52,731
-73% -$3.62M 0.02% 793
2017
Q3
$4.62M Buy
72,496
+18,382
+34% +$1.15M 0.08% 421
2017
Q2
$3.38M Buy
54,114
+35,009
+183% +$2.07M 0.07% 484
2017
Q1
$1.02M Buy
19,105
+10,789
+130% +$583K 0.02% 781
2016
Q4
$445K Sell
8,316
-2,053
-20% -$104K 0.01% 889
2016
Q3
$539K Buy
10,369
+5,865
+130% +$297K 0.02% 813
2016
Q2
$214K Buy
+4,504
New +$213K 0.01% 778
2016
Q1
Sell
-42,514
Closed -$2.04M 840
2015
Q4
$2.04M Buy
42,514
+32,248
+314% +$1.46M 0.16% 248
2015
Q3
$422K Sell
10,266
-93,142
-90% -$4.32M 0.07% 438
2015
Q2
$4.99M Sell
103,408
-11,657
-10% -$556K 0.2% 179
2015
Q1
$5.33M Buy
115,065
+61,320
+114% +$2.76M 0.21% 151
2014
Q4
$2.31M Buy
53,745
+47,088
+707% +$1.91M 0.12% 394
2014
Q3
$246K Buy
+6,657
New +$228K 0.02% 647

Other funds holding ZTS

AHL Partners's ZTS Position: Q4 2017 in Review

AHL Partners reduced its Zoetis (ZTS) stake by 73% in Q4 2017, selling an estimated $3.62M and leaving 19,765 shares worth $1.42M. The position accounts for 0.02% of the portfolio, ranked #793.

AHL Partners first reported a position in ZTS in Q3 2014 and has held it in 13 quarters since. The position peaked at $5.33M in Q1 2015. 854 funds tracked by Wall St. Rank hold ZTS as of Q4 2017.

  • AHL Partners held 19,765 shares of Zoetis worth $1.42M as of Q4 2017.
  • AHL Partners sold 52,731 Zoetis shares in Q4 2017, an estimated $3.62M.
  • Zoetis made up 0.02% of AHL Partners's portfolio in Q4 2017, its #793 holding.
  • AHL Partners first reported a position in Zoetis in Q3 2014 and has held it in 13 quarters since.
  • AHL Partners's Zoetis position peaked at $5.33M in Q1 2015.
  • 854 funds tracked by Wall St. Rank held Zoetis as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.